156 related articles for article (PubMed ID: 35456960)
1. High eEF1A1 Protein Levels Mark Aggressive Prostate Cancers and the In Vitro Targeting of eEF1A1 Reveals the eEF1A1-actin Complex as a New Potential Target for Therapy.
Bosutti A; Dapas B; Grassi G; Bussani R; Zanconati F; Giudici F; Bottin C; Pavan N; Trombetta C; Scaggiante B
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35456960
[TBL] [Abstract][Full Text] [Related]
2. Dissecting the expression of EEF1A1/2 genes in human prostate cancer cells: the potential of EEF1A2 as a hallmark for prostate transformation and progression.
Scaggiante B; Dapas B; Bonin S; Grassi M; Zennaro C; Farra R; Cristiano L; Siracusano S; Zanconati F; Giansante C; Grassi G
Br J Cancer; 2012 Jan; 106(1):166-73. PubMed ID: 22095224
[TBL] [Abstract][Full Text] [Related]
3. Effects of eEF1A1 targeting by aptamer/siRNA in chronic lymphocytic leukaemia cells.
Dapas B; Pozzato G; Zorzet S; Capolla S; Macor P; Scaggiante B; Coan M; Guerra C; Gnan C; Gattei V; Zanconati F; Grassi G
Int J Pharm; 2020 Jan; 574():118895. PubMed ID: 31862491
[TBL] [Abstract][Full Text] [Related]
4. A rapid and specific method to simultaneously quantify eukaryotic elongation factor 1A1 and A2 protein levels in cancer cells.
Bosutti A; Kalaja O; Zanconati F; Dapas B; Grassi G; Passamonti S; Scaggiante B
J Pharm Biomed Anal; 2019 Nov; 176():112814. PubMed ID: 31450069
[TBL] [Abstract][Full Text] [Related]
5. [Eukaryotic translation elongation factor 1A1 positively regulates NOB1 expression to promote invasion and metastasis of hepatocellular carcinoma cells
Zhang W; Xiang M; Zheng C; Chen L; Ge J; Yan C; Liu X
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1195-1202. PubMed ID: 30377124
[TBL] [Abstract][Full Text] [Related]
6. Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer.
Hao J; Ci X; Xue H; Wu R; Dong X; Choi SYC; He H; Wang Y; Zhang F; Qu S; Zhang F; Haegert AM; Gout PW; Zoubeidi A; Collins C; Gleave ME; Lin D; Wang Y
Eur Urol; 2018 Jun; 73(6):949-960. PubMed ID: 29544736
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of the elongation factor 1A1 relates to muscle proteolysis and proapoptotic p66(ShcA) gene transcription in hypercatabolic trauma patients.
Bosutti A; Scaggiante B; Grassi G; Guarnieri G; Biolo G
Metabolism; 2007 Dec; 56(12):1629-34. PubMed ID: 17998013
[TBL] [Abstract][Full Text] [Related]
8. High eukaryotic translation elongation factor 1 alpha 1 expression promotes proliferation and predicts poor prognosis in clear cell renal cell carcinoma.
Bao Y; Zhao TL; Zhang ZQ; Liang XL; Wang ZX; Xiong Y; Lu X; Wang LH
Neoplasma; 2020 Jan; 67(1):78-84. PubMed ID: 31777262
[TBL] [Abstract][Full Text] [Related]
9. YAP is closely correlated with castration-resistant prostate cancer, and downregulation of YAP reduces proliferation and induces apoptosis of PC-3 cells.
Sheng X; Li WB; Wang DL; Chen KH; Cao JJ; Luo Z; He J; Li MC; Liu WJ; Yu C
Mol Med Rep; 2015 Oct; 12(4):4867-76. PubMed ID: 26126522
[TBL] [Abstract][Full Text] [Related]
10. eEF1A1 promotes colorectal cancer progression and predicts poor prognosis of patients.
Fan AH; Zhao X; Liu H; Li D; Guo T; Zhang J; Duan L; Cheng H; Nie Y; Fan D; Zhao X; Lu Y
Cancer Med; 2023 Jan; 12(1):513-524. PubMed ID: 35607944
[TBL] [Abstract][Full Text] [Related]
11. Analytical Validation and Clinical Qualification of a New Immunohistochemical Assay for Androgen Receptor Splice Variant-7 Protein Expression in Metastatic Castration-resistant Prostate Cancer.
Welti J; Rodrigues DN; Sharp A; Sun S; Lorente D; Riisnaes R; Figueiredo I; Zafeiriou Z; Rescigno P; de Bono JS; Plymate SR
Eur Urol; 2016 Oct; 70(4):599-608. PubMed ID: 27117751
[TBL] [Abstract][Full Text] [Related]
12. RGS2 is prognostic for development of castration resistance and cancer-specific survival in castration-resistant prostate cancer.
Linder A; Larsson K; Welén K; Damber JE
Prostate; 2020 Aug; 80(11):799-810. PubMed ID: 32449815
[TBL] [Abstract][Full Text] [Related]
13. Significant Association of Caveolin-1 and Caveolin-2 with Prostate Cancer Progression.
Sugie S; Mukai S; Yamasaki K; Kamibeppu T; Tsukino H; Kamoto T
Cancer Genomics Proteomics; 2015; 12(6):391-6. PubMed ID: 26543085
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel binding protein of FAT10: eukaryotic translation elongation factor 1A1.
Yu X; Liu X; Liu T; Hong K; Lei J; Yuan R; Shao J
Dig Dis Sci; 2012 Sep; 57(9):2347-54. PubMed ID: 22569823
[TBL] [Abstract][Full Text] [Related]
15. Contradictory mRNA and protein misexpression of EEF1A1 in ductal breast carcinoma due to cell cycle regulation and cellular stress.
Lin CY; Beattie A; Baradaran B; Dray E; Duijf PHG
Sci Rep; 2018 Sep; 8(1):13904. PubMed ID: 30224719
[TBL] [Abstract][Full Text] [Related]
16. Elevated circulating tissue inhibitor of metalloproteinase 1 (TIMP-1) levels are associated with neuroendocrine differentiation in castration resistant prostate cancer.
Gong Y; Chippada-Venkata UD; Galsky MD; Huang J; Oh WK
Prostate; 2015 May; 75(6):616-27. PubMed ID: 25560638
[TBL] [Abstract][Full Text] [Related]
17. Subgroups of Castration-resistant Prostate Cancer Bone Metastases Defined Through an Inverse Relationship Between Androgen Receptor Activity and Immune Response.
Ylitalo EB; Thysell E; Jernberg E; Lundholm M; Crnalic S; Egevad L; Stattin P; Widmark A; Bergh A; Wikström P
Eur Urol; 2017 May; 71(5):776-787. PubMed ID: 27497761
[TBL] [Abstract][Full Text] [Related]
18. MYBL2 disrupts the Hippo-YAP pathway and confers castration resistance and metastatic potential in prostate cancer.
Li Q; Wang M; Hu Y; Zhao E; Li J; Ren L; Wang M; Xu Y; Liang Q; Zhang D; Lai Y; Liu S; Peng X; Zhu C; Ye L
Theranostics; 2021; 11(12):5794-5812. PubMed ID: 33897882
[No Abstract] [Full Text] [Related]
19. Aptamer targeting of the elongation factor 1A impairs hepatocarcinoma cells viability and potentiates bortezomib and idarubicin effects.
Scaggiante B; Farra R; Dapas B; Baj G; Pozzato G; Grassi M; Zanconati F; Grassi G
Int J Pharm; 2016 Jun; 506(1-2):268-79. PubMed ID: 27094354
[TBL] [Abstract][Full Text] [Related]
20. CD38 in Advanced Prostate Cancers.
Guo C; Crespo M; Gurel B; Dolling D; Rekowski J; Sharp A; Petremolo A; Sumanasuriya S; Rodrigues DN; Ferreira A; Pereira R; Figueiredo I; Mehra N; Lambros MBK; Neeb A; Gil V; Seed G; Terstappen L; Alimonti A; Drake CG; Yuan W; de Bono JS;
Eur Urol; 2021 Jun; 79(6):736-746. PubMed ID: 33678520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
